Cigna’s stock price was down 11.46 percent at market close March 8. However, the deal sent Express Scripts shares 8.58 percent higher.
Cigna and Express Scripts anticipate the deal will close by the end of 2018.
More articles on payer issues:
2 senators call on HHS Secretary Alex Azar to probe Anthem’s ED rules
Aetna gives $200k toward protest against gun violence
Cigna opens Middle East headquarters
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
